OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

Page
MessagefromtheChairmanandtheChiefExecutive
ReportoftheTrustees 5to20
ReportoftheIndependentAuditors 21to24
StatementofFinancialActivities 25
BalanceSheet 26
CashFlowStatement 28
NotestotheCashFlowStatement 29

Risk Actions

Insufficientincometooperatesustainably,leadingto| WiththewithpressuresontheUKeconomy
asustained reductioninfreereserves causinghighinflationandcostoflivingconcerns
forindividuals,thefundraisingenvironmentis
anticipatedtobeextremelydifficultforallcharities.
TheCharityhasestablishedreserveswhichwill
supportitintheimmediatefuture,butweareaware
thatgeneratingincomewillbechallengingandthat
therearea numberofareaswhereweneedtoinvest
topositiontheCharitytomeetthenextphaseof

itsgrowth.Asa resultweareforecastingtoneedto

drawsignificantlyonthesereservesinthenextone

totwoyears.

Wearelookingtoincreaseanddiversifyour

incomestreamsbyenhancingandinvestinginour

fundraisingteamandactivities.Costreduction

measureshavealsobeenputinplacethroughFY23

whichwillbesustainedintoFY24andbeyond.


Risk

Actions

Maintainingstrongandeffectiverelationshipswith

TheCharityhasa numberofkeyrelationships
keystakeholderssuchasresearchpartnersandmajor withkeypartnersanddonorswhichareessential
donors toeitherfundouractivitiesatthecurrentlevelor
todelivercollaborativeprojectssuchasprostate
cancerdetection.Weareinvestinginimprovingand
enhancingourcommunicationsandrelationships
withtheseorganisationsandindividualsto
strengthentheselinks.

Insufficientseniororkeystaffduetolossofor

Recruitmentandretentionisa majorissueforall
inabilitytorecruitorretainkeypersonnel. organisationsatthemoment.Thecostofliving
crisisandshortageofavailableskilledpersonnelis
asignificantriskbothforcontrollingcostsandfor
maintainingtheworkforceneededtodeliver.
TheCharityalwaysseekstospendasmuchas
possibleofourfundsonourcharitablegoals,and
thereforedoesnothavea largemanagementteam.
Consequently,werelyona smallnumberofkey
people,mostnotablytheCEO,todrivetheCharity
forwardsandtomanageday-to-dayactivities.
Overthepastyearwehavetakenseveral
positivestepstoaddressthis.Mostnotablythe
implementationofa SeniorLeadershipTeammade
upofsevenkeystaffmembers,plustheCEO.This

stepisa substantialoneasitmovestheCharityaway

fromhavingheavyorsolerelianceononeortwo

individualsforthedaytodayrunningofoperations.

Wearelookingatsuccessionplanningand

implementinga developmentpipelinetosafeguard

againsttheriskoflosingkeypeople.Given

thespecialisednatureandscaleoftheCharity

thisrepresentsa particularchallengeinsome

departments,whichwearebeginningtoactively

engageintodeterminethebestwayforwards.



Insufficientvolunteerstosupportourservice


Likemostcharities,werelyheavilyona volunteers

delivery

inmanyareasofouractivities,fromfundraising

tosupportindeliveringourcharitableactivities.

Thereiscurrentlya nationalshortageofvolunteers

tofosterdogswhichisbeginningtoimpactonthe

numberofdogswecantrainanddeploy.

WeareexploringothermodelsforourMAAD

workwhichdonotrequiretheuseofanyfosterers,

withoutimpactingonourcoreprinciplethatallour

dogsshouldliveinhomes,notkennels.Greateruse

ofclients’owndogsmighthelpusinthisregard.We

arealsoexploringtheestablishmentofregionalhubs

whichcouldallowus totargetnewgeographicareas

forrecruitingfosterers.


Risk

Actions

InvestmentinFundraisingteamtoreturnthecharity

Withthecharityintentiallyrecordinga deficitfor
toa breakevenposition the2022/23year(andwitha similarprojectionfor
2023/24),a deliberateandcoordinatedendeavor
hasbeenundertakentoincreasetheproportion
ofexpenditurespentonfundraisingactivitiesand
relatedinitiatives.
Withthisinvestment,itisimportantthatthe
additionalexpenditureworkstoyieldanincreasein
ourunderlyingincome,andreturnsthecharitytoa
breakevenposition.
Thissupportstheoverarchingobjectivetoreturnthe
charitytoa stateofequilibrium,whereunderlying
incomematchesunderlyingexpenditure.


ReductioninBioResearchfundingandpressureson

DuringtheCOVID-19pandemic,ourBioresearch

ourNHSpartners
teamwasthefocusofthecharityandreceiveda high
numberofdonationssupportingresearchintohow

caninedetectioncouldsupporttheUKduringthe

pandemic.

Followingthisperiod,therehasbeena significant

reductioninthefundingavailableforBioresearch

projects.Thisissupplementedbyincreasing

pressuresontheNHS,narrowingtheabilityofNHS

Truststocollaboratewithusonresearchworks

astheirresourcesaredivertedtowardsfrontline

support.

Asa resultwehavereducedthebalanceofresources

allocatedtoourBioresearchdepartment.Weexpect

thecurrent,reducedsizeoftheteamtocontinue

untilfundingforfutureprojectsissecured.A risk

existsthatiftheteamsizeneedstobereduced

furtherthatthecumulativeknowledgeandexpertise

inBioresearch,whichhasbeenbuiltupovermany

years,islostintheshortterm.Thislossofknowledge

andteamexperiencewouldtake18monthsormore

toreplace.

Risk Actions

CompliancewithDBSandSafeguardingstandards

ItisvitalthatMDDmaintainsitshighstandardswith
regardstosafeguardingthevulnerablepeoplewe
support.
AssuchanongoingreviewandrenewalofDisclosure
andBarringService(DBS)policies,proceduresand
checkingforallstaffandvolunteerswhoencounter
vulnerableindividualsisinplace.
Similarlywereviewalloursafeguardingtraining:all
staffdeliveringourworkwhichMDDhasidentified
asmeaningtheymayhavecontactwithvulnerable
adultsorchildrenmustachieveLevel2 safeguarding
trainingstandards(withanyothermemberofstaff
maintainingLevel1).
Aleadershipstructureisinplacetooverseethe
maintenanceofsafeguardingstandards,which
includesa Trusteesafeguardinglead,aswellasan
employeeleadwhositsontheSeniorLeadership
Team.

Dataqualityimprovement

Toenhanceourfundraisingcapabilities,we
acknowledgetheimperativeofmaintaininga
robustlevelofdataquality,specificallycuratedfor
fundraisingpurposes,allthewhileupholdingGDPR
complianceinthehandlingofthisinformation.
Ourcommitmenttostaffproficiencyindatabase

systemsremains,andisupheldthroughongoing

trainingofrelevantstaff.Additionally,wehave

undertakenanevaluationofhistoricaldataviaa

datacleansingassessment.Whileweadheretoall

GDPRprotocols,furthermeasurescanbetakento

consistentlyelevatethequalityofourfundraising

data.This,inturn,willenableourdatatodrive

decisionmaking.



Cybersecurityandlossofinformationrisk


Astechnologycontinuestoevolve,thedemandfor

anacceleratedrateofprogresstoremaininstep,as

wellasthepotentialriskslinkedtonotembracing

thischange,becomemorepronounced.Cyber

securityattacksarebecomingmoreregularacross

allorganisationsandcanhaveanenormousadverse

impact.

MDDhasrecentlyinvestedinourITinfrastructure

tobringusinlinewithsimilarlysizedorganisations,

enablingourstafftoworkefficientlyandeffectively,

whilstalsofutureproofingtheCharityforexpected

technologydevelopments.

Inordertocontinuallymovewiththese

developmentsweemploya dedicatedITexpert

withinthecharity,andhavemovedmanyofour

supportsystemstoa dedicatedITsupportpartner.

19 October 2023

2023 2022
Unrestricted Restricted Totalfunds Totalfunds
fund funds
Notes
£
£ £ £
INCOMEANDENDOWMENTSFROM
Donationsandlegacies 3 1,137,365 688,492 1,825,857 2,474,281
Othertradingactivities 4 47,985 - 47,985 63,663
Investmentincome 5 15,193 - 15,193 672
Governmentgrants 5 - - - 13,439

1,200,543


688,492

1,889,035

2,552,055
Total
EXPENDITUREON
Raisingfunds 6 137,920 76,429 214,349 163,202
Charitableactivities 7
Dogtraining 354,490 174,141 528,631 420,812
Assistancedogplacementandaftercare 571,073 318,383 889,456 810,751
BioDetectionresearchprojects 474,376 27,093 501,469 535,131
Educationandawareness 136,264 0 136,264 158,483
Volunteerliaison
121,965


102,857

224,822

195,617
Total 1,796,088 698,903 2,494,991 2,283,996
NETINCOME
(595,545)


(10,411)

(605,956)

268,059
Transfersbetweenfunds 18
-


-


-


-
Netmovementinfunds (595,545) (10,411) (605,956) 268,059
RECONCILIATIONOFFUNDS
Totalfundsbroughtforward 4,218,207 594,746 4,812,953 4,544,894
TOTALFUNDSCARRIEDFORWARD
3,622,663


584,333


4,206,996


4,812,953

2023 2022
Unrestricted Restricted Totalfunds Totalfunds
fund funds
Notes
£
£ £ £
FIXEDASSETS
Tangibleassets 12 1,738,013 - 1,738,013 1,807,911
Investments 13 4 - 4 5

1,738,017




-


1,738,017


1,807,916
CURRENTASSETS
Stocks 14 5,992 - 5,992 10,648
Debtors 15 396,625 - 396,625 728,346
Cashatbankandinhand 1,643,571 584,333 2,227,904 2,512,181

2,163,438

584,333


2,630,521

3,251,175
CREDITORS
Amountsfallingduewithinoneyear 16 (161,541) - (161,451) (246,138)
NETCURRENTASSETS
1,884,647

584,333


2,468,980

3,005,037
TOTALASSETSLESSCURRENT
3,622,663


584,333





4,206,996


4,812,952
LIABILITIES




NETASSETS
3,622,663

584,333


4,206,996

4,812,952
FUNDS
Unrestrictedfunds 18 3,622,663 4,218,207
Restrictedfunds 18 §84,333 594,746
TOTALFUNDS
4,206,996

4,812,952

2023 2022
Unrestricted Restricted Totalfunds Totalfunds
fund funds
Notes
£
£ £ £
FIXEDASSETS
Tangibleassets 12 1,738,013 - 1,738,013 1,807,911
Investments 13 5 - 5 5

1,738,018




-


1,738,018


1,807,916
CURRENTASSETS
Stocks 14 5,992 - 5,992 10,648
Debtors 15 396,625 - 396,625 728,346
Cashatbankandinhand 1,643,571 584,333 2,227,904 2,512,181

2,046,188


584,333





2,630,521


3,251,175
CREDITORS
Amountsfallingduewithinoneyear 16 (161,541) - (161,541) (246,138)
NETCURRENTASSETS

1,884,647



584,333








2,468,980



3,005,036
TOTALASSETSLESSCURRENT
3,622,664


584,333





4,206,997


4,812,952
LIABILITIES




NETASSETS
3,622,664


584,333





4,260,997


4,812,952
FUNDS
Unrestrictedfunds 18 3,622,664 4,218,207
Restrictedfunds 18 584,333 504,746
TOTALFUNDS
4,206,997

4,812,952
2023 2022
Notes
Netcash(usedin)providedbyoperating
activities
A (246,340) (35,371)
Cashflowsfrominvestingactivities:
Purchaseoftangiblefixedassets
(54,631) (127,235)
Saleoftangiblefixedassets 1,500
Investmentincome 15,193 672
Netcash(usedin)investingactivities " (37,937) (126,563)
Changeincashandcashequivalentsinthe
reportingperiod
(284,277) (161,934)
Cashandcashequivalentsatthebeginning
ofthereportingperiod
2,512,181 2,674,115
Cashandcashequivalentsattheendofthe
reportingperiod
2,227,904 2,012,181

2023 2022
£ £
Netincomeforthereportingperiod(asperthestatementof
financialactivities) (605,956) 268,059
Adjustmentsfor:
Depreciationcharges 122,700 109,657
Lossonsaleoffixedassets 330 -
Interestreceived (15,193) (672)
(Increase)/ Decreaseinstocks 4,656 (3,341)
(Increase)/ Decreaseindebtors 331,721 (511,026)
Increase/ (Decrease)increditors
(84,598)

101,952
Netcash(usedin)providedbyoperatingactivities (246,340) (35,371)


Asat

Cashflow
Asat

1/4/2022
31/3/2023
2,512,181 (284,277) 2,227,904

2,512,181

(284,277)

2,227,904

Freeholdproperty -2%oncost
Fixturesandfittings -Straightlineover3 years
Motorvehicles -Straightlineover3 years

2023 2022
£ £
Donationsandgrants 1,567,452 1,750,483
Legacies 258,405
723,798
1,825,857
2,474,281
4. OTHERTRADINGACTIVITIES— CharitableGroup
2023 2022
£ £
Fundraisingevents 26,760 37,304
Merchandisesales 21,225 19,859
Consultancy
-

6,500

47,985


63,663
5. OTHERINCOME-—CharitableGroup
2023 2022
InvestmentIncome £ £
Depositaccountinterest 15,193 672
GovernmentGrants £ £
UKGovernment:Jobretentionschemegrants -
13,439

Raisingdonationsandlegacies— CharitableGroup
2023 2022
£ £
Wages 164,425 124,254
Eventcosts 7,765 6,648
Travel 3,280 1,030
Onlinegivingadminfees 9,831 9,318
Printing 1,026 1,386
Equipmentunder£1,000 5,568 1,642
Directoverheads— DeprecationFreeholdProperty
5,957

5,700

197,852

149,978
Othertradingactivities
2023 2022
£ £
Purchasesofgoodsforresale
16,667

43,224
Aggregateamounts

214,349


163,202
7. CHARITABLEACTIVITIESCOSTS —-CharitableGroup
Currentyear Direct Support 2023Total 2022Total
Costs costs
£ £ £ £
Dogtraining 356,774 171,857 528,631 420,812
Assistancedogplacement 600,558 288,897 889,456 810,751
BioDetectionresearch 338,501 162,968 501,469 535,131
Educationandawareness 91,819 44,445 136,264 158,483
Volunteerliaison 152,228 72,594 224,822 195,617
Total

1,539,880


740,761


2,280,642


2,120,794
Comparativeyear Direct Support 2022Total
Costs costs
£ £ £
Dogtraining 281,584 139,228 420,812
Assistancedogplacement §82,924 227,826 810,751
BioDetectionresearch 395,903 139,228 535,131
Educationandawareness 101,527 56,956 158,483
Volunteerliaison 126,004 69,614 195,617
Total
1,487,942

632,852

2,120,794

Currentyear Management Finance Governance 2023 2022
Total Total
£ £ £ £ £
Dogtraining 163,620 575 7,662 288,897 139,228
Assistancedogplacement 275,050 967 12,880 162,968 227,826
BioDetectionresearch 155,157 546 7,265 44,445 139,228
Educationandawareness 42,315 149 1,981 72,594 56,956
Volunteerliaison 69,115 243 3,236 288,897 69,614
Total

705,258


2,480


33,024


740,761


632,852
Comparativeyear Management Finance Governance 2022
Total
£ £ £ £
Dogtraining 135,435 441 3,352 139,228
Assistancedogplacement 221,620 721 5,485 227,826
BioDetectionresearch 135,435 441 3,352 139,228
Educationandawareness 55,405 180 1,371 56,956
Volunteerliaison 67,718 220 1,676 69,614
Total
615,613

2,003

15,236

632,852

2023
Governance Dogtraining Assistance BioDetection Education Volunteer 2023
dog research and liaison Total
placement awareness
£ £ £ £ £ £
Auditors’remuneration- Audit 7,603 12,782 7,210 1,966 3,212 32,773
DBSchecks 58 98 55 15 25 251
Boardmeetingcosts
Total

7,662


12,880


7,265


1,981



3,236


33,024
2022
Governance Dogtraining Assistance
BioDetection
Education and Volunteer 2022
dog
research
awareness liaison Total
placement
£ £ £ £ £ £
Auditors’remuneration- Audit 3,306 5,411 3,307 1,353 1,653 15,030
DBSchecks 38 62
37
15 19 171
Boardmeetingcosts 8 12
8
3 4 35
Total
3,352

§,485


3,352

1,371

1,676

15,236

2023 2022
£ £
Auditors'remuneration 25,663 15,030
AdditionalAuditfeeinrespectof2022 7,110 -
Depreciation- ownedassets 122,700 109,657
Operatingleasecharges
13,946

7,736
Deprecationwasdirectlyallocatedtoactivitiesasfollows:
2023 2022
£ £
Raisingdonationsandlegacies 5,753 5,700
Dogtraining 15,375 15,269
Assistancedogplacementandaftercare 15,375 15,268
Educationandawareness 1,918 1,900
Volunteerliaison 1,918 1,900
Management 82,361 69,620

122,700

109,657

2022 2021
£ £
Wagesandsalaries 1,419,454 1,334,447
Socialsecurity costs 131,184 110,646
Pensioncosts
63,162

48,187

1,613,801

1,493,280
2023 2022
Raisingfunds 5 4
Dogtraining,veterinaryandwelfare 9 9
Assistancedogplacementandaftercare 11 13
BioDetectionresearchprojects 11 11
Educationandawareness 2 2
Volunteerliaison 4 4
Executive 3 4
Facilities 2 2
Finance 4 4
InformationTechnology 1 -
Humanresources 2 2
54 55
2023 2022
£80,001 - £90,000 1 1
£60,000 - £70,000 0 1

Tangible FixedAssets
Freehold Fixtures Motor Total
property and vehicles
fittings
COST
At1%April2022 1,900,107
357,270
73,233 2,330,610
Additions 17,640
36,992
- 54,631
Disposals -
-
(5,490) (5,490)
At31%March2023

1,917,747





394262


67,743




2,379,752
DEPRECIATION
At1°April2022 211,718
248,422
62,559 522,699
Chargefortheyear 38,355
76,608
7,737 122,700
Disposals -
-
(3,660) (3,660)
At315!March2023

250,073





325,030


66,636




641,739
NETBOOKVALUE
At31°March2023
1,667,674



69,232

1,107


1,738,013
At31%March2022 1,688,389


108,848
10,674

1,807,911


Name

Company

Natureof

Classof

|% held

Resultforthe


Capitaland
registration business shares directly year reserves
number[4]
(Englandand
Wales)

MDD

08709010

Dormant

Ordinary

|100%

-

£1
Enterprises (2022:£1)
Limited[2]


Millfield

06312801


Property


Ordinary

|75%


Yearended31




Yearended31

Greenway

management

July2023:ENil


|July2023:£136

BusinessPark

(2022:ENil)


(2022:£136)

Management


Limited[2]



Canine

12646135


BioDetection


|Ordinary

|100%


ENil




£1

Diagnostic

Disease

(2022:Dormant)


(2022:£1)

Innovations

Research


Limited[3]

services





14.
STOCKS— CharityandGroup
2023 2022
£ £
Stocks 5,992
10,648
15.
DEBTORS- Group
2023 2022
£ £
Amountsfallingduewithinoneyear:
Legacydebtors 283,519 392,500
Prepaymentsandaccruedincome 24,410 232,670
Otherdebtors
88,696

123,485

396,625

748,655
DEBTORS- Charity 2023 2022
£ £
Amountsfallingduewithinoneyear:
Legacydebtors 283,519 392,500
Prepaymentsandaccruedincome 24,410 232,670
Otherdebtors 88,696 123,485
NetIntercompanyAccounts— CDILtd -
396,625
748,655

2023 2022
£ £
Tradecreditors 64,628 172,520
Socialsecurityandothertaxes 31,452 28,837
Accrualsanddeferredincome 65,457 44,776
Currentaccountswithdormantsubsidiaries 4 5


161,541


246,138
CREDITORS:AMOUNTSFALLINGDUEWITHINONEYEAR- CharityOnly
2023 2022
£ £
Tradecreditors 64,628 172,520
Socialsecurityandothertaxes 31,452 28,837
Accrualsanddeferredincome 65,457 44,776
Currentaccountswithsubsidiaries 5 5


161,541


246,138
LEASINGAGREEMENTS
Minimumleasepaymentsundernon-cancellableoperatingleasesfalldueasfollows:
2023 2022
£ £
Withinoneyear 14,096 12,833
Betweenoneandfiveyears 21,867 7,402

35,963

20,235

Currentyear At1/4/22 Income Expenditure Transfers At31/3/23
between
funds
£ £ £ £ £
Unrestrictedfunds
Generalfund 4,218,207 1,200,543 (1,796,088) - 3,622,663
Restrictedfunds
Cancerstudies 8,308 - - - 8,308
Namea puppy 3,070 - (3,070) -
Medicalalertassistance 467,731 62,350 (168,740) - 346,341
dogs
BioDetection(COVID-19) - 25,000 (25,000) - -
Equipment 5,637 2,441 (2,093) 5,984
Regionaldevelopment 125,000 500,000 (500,000) 125,000
BioDetectionDog - 88,700 - - 88,700
sponsorship
Government - 10,000 - - 10,000
ApprenticeshipLevy
Scheme


594,746


688,492


(698,903)


-


584,333

TOTALFUNDS


4,812,953


1,889,035


(2,494,991)


-


4,206,996
Comparativeyear At1/4/21 Income Expenditure Transfers At31/3/22
between
funds
£ £ £ £ £
Unrestrictedfunds
Generalfund 4,052,280 1,435,585 (1,293,373) 23,715 4,218,207
Restrictedfunds
Cancerstudies 8,308 - - - 8,308
Namea puppy 3,070 - - - 3,070
Medicalalertassistance 184,531 373,550 (105,350) - 452,731
dogs
BioDetection(COVID-19} 47,092 232,251 (279,343) - -
Equipment 10,472 5,080 - (9,915) 5,637
BioLabrefurbishment 14,140 150 (490) (13,800) -
Regionaldevelopment 225,001 475,000 (575,001) - 125,000
BioDetectionDog - 30,439 (30,439) - -
sponsorship


492,614


1,116,470


(990,623)


(23,715)


594,746
TOTALFUNDS

4,544,894

2,552,055

(2,283,996)

:

4,812,953


CanineDiagnisoticInnovationsLtd- SummaryProfitandLossAccount

CanineDiagnisoticInnovationsLtd- SummaryProfitandLossAccount

Fortheperiodended31March2023

2023

‘9Monthsto31
March2022
£ £

Turnover

338,501

0


CostofSales


(338,501)

0


GrossProfit/ (Loss)


0

0


Tax


0

0


Profit(orloss)forthefinancialyear


0

0

CanineDiagnisoticInnovationsLtd- SummaryBalanceSheet

Fortheperiodended31March2023




2023

9Monthsto31


March2022


£

£



Calledupsharecapitalnotpaid


1


4



Prepaymentsandaccruedincome


0


0



Totalassetslesscurrentliablities


0


1



Creditors:amountsfallingdueaftermore


0


0


thanoneyear



TotalNetAssets


0


0



Calledupsharecapital


1


1